Dr. Trevor Dummer and Mohadeseh Ahmadi at #CCRC2023

Dr. Trevor Dummer will be attending the Canadian Cancer Research Conference. Dr. Dummer is the co-Scientific Director for CanPath, an Associate Professor at the School of Population and Public Health at the University of British Columbia, the Canadian Cancer Society Chair in Primary Prevention, and Affiliated Scientist, BC Cancer. Dr. Dummer’s research interests include how the environment, communities and neighbourhoods influence health outcomes, including cancer.  Dr. Dummer will be in attendance at the Canadian Cancer Research Conference along with his student, Mohadeseh Ahmadi. Mohadeseh is a MSc student in the School of Population and Public Health at the University of British Columbia. They will be presenting on the association between traffic-related air pollution and breast cancer risk in post-menopausal women in Alberta’s Tomorrow Project in a lightning session on Tuesday, November 14th at 10:40am AST.    

Dr. Jennifer Vena and Dr. Rachel Murphy at #CCRC2023

Dr. Jennifer Vena and Dr. Rachel Murphy will be attending the Canadian Cancer Research Conference from Alberta and British Columbia. Dr. Vena is the Scientific Director of Alberta’s Tomorrow Project and a Research Scientist at CancerControl Alberta with Alberta Health Services. Dr. Vena’s research interests focus on lifestyle behaviours and prevention of cancer and chronic diseases, as well as population cohort science, and involves scientific, strategic, and operational elements. Dr. Vena will be presenting a poster on the dietary screener that was developed to assess adherence to Canada’s Food Guide and how it could be used for cancer prevention research. Posters will be up for the duration of the conference and during viewing sessions on Sunday, November 12th from 12-1:30pm AST and Monday, November 13th from 1:10-2:40pm AST.  Dr. Murphy is a Senior Scientist at BC Cancer and an Associate Professor at the School of Population and Public Health at the University of British Columbia. Dr. Murphy’s research interests include reducing the risk of cancer through modifiable lifestyle factors, with a focus on healthy eating and body weight. Additional interests include older adults and other populations with increased risk of cancer, knowledge translation of nutrition evidence, and metabolomics; the study of small molecules in biological systems that may provide insight on pathways linking lifestyle factors and disease.   Dr. Murphy will be presenting at and chairing a session with Patient Partner, Rachelle Bould on Reducing Your Risk of Cancer on Tuesday, November 14th at 9:00am AST. The presenters include:  Dr. Rachel Murphy (University of British Columbia, BC Cancer) speaking about diet, geographies and risk for cancer  Dr. Laura Struik (University of British Columbia) speaking about factors influencing youth vaping uptake  Dr. Paul Demers (Occupational Cancer Research Centre, Ontario Health) speaking about the etiology of rare cancers in a large occupational cohort  Umaima Abbas (University of Western Ontario) speaking about the effectiveness and cost-effectiveness of population level policies to reduce alcohol use   

Nova Scotian Institute of Science – Dr. Derrick Lee Presentation

Dr. Derrick Lee, Assistant Professor at St. FX University recently gave an excellent presentation on “How Environment and Genes Impact Colorectal Cancer Risk in Atlantic Canada” to the Nova Scotian Institute of Science. “Like many Atlantic Canadians, cancer has affected me directly and indirectly, and there are many factors that influence individual risk of cancer. Many of us are familiar with the risks associated with smoking, as well as the risk when there is a family history of the disease, and yet none of these factors are unique to Atlantic Canada. In today’s talk, I’m going to describe one of my projects that takes aim at explaining why the risk of colorectal cancer.” Dr. Derrick Lee, Saint Francis Xavier University. Dr. Lee’s research on environment and gene interactions in colorectal cancer risk uses data and biological samples from Atlantic PATH and the BC Generations Project. You can find the presentation on the Nova Scotian Institute of Science’s YouTube page: https://www.youtube.com/watch?v=CeU3nQntpnE.    

Webinar: Using CanPath to Support Innovative Health Research 

Using CanPath to Support Innovative Health Research  Join our colleagues, Dr. Parveen Bhatti (Scientific Director, BC Generations) and Sheraz Cheema (Data Manager, CanPath) on Wednesday, October 11th to learn about CanPath, types of questions the data can be used to address, and how the data can be accessed. Registration: https://t.co/m8PU92M881  

Most CanPath study participants had infection-acquired antibodies but few suspected COVID-19

Dr. Victoria Kirsh presented at a CanPath webinar this week to present results from the SUPPORT-Canada study, funded by the federal COVID-19 Immunity Task Force (CITF). Data and blood spot samples were used from 22,300 participants from Atlantic PATH, CARTaGENE, the Ontario Health Study, Manitoba Tomorrow Project, Alberta’s Tomorrow Project, and BC Generations. Key findings include: 62% of participants had a COVID-19 infection based on anti-N measured antibody levels. Among those, 86% did not suspect they had ever had COVID-19. 95% of the COVID-19 infections were observed during the Omicron period. Risk of infection was increased among younger individuals, males, essential workers, and those who travelled. Participants with a reported COVID-19 infection reported symptoms from mild to severe, but few required hospitalization. The effectiveness of full or booster vaccination in preventing COVID-19 Omicron infection is short-term, only lasting 4 months. Time since last dose is a more important determinant of protection against infection than the number of doses. Antibody levels are correlates of vaccine-induced protection. Prior COVID-19 infection protects against reinfection for 8 months. The CanPath SUPPORT-Canada study has provided important findings related to the COVID-19 pandemic, vaccines and infections. With only 4 months of protection, these findings suggest that booster campaigns could be strategically used to rapidly boost immunity before upcoming waves of infection. Further, the longitudinal nature of CanPath participants ensures that we have a nationally representative population that can be followed for years to come (e.g., impact of Long COVID, future vaccinations, etc.). Link to recorded webinar: To come Link to webinar slide deck: https://www.covid19immunitytaskforce.ca/wp-content/uploads/2023/05/canpath-webinar-may-2023.pdf Link to CITF’s post: https://www.covid19immunitytaskforce.ca/most-canpath-study-participants-had-infection-acquired-antibodies-but-few-suspected-covid-19/